Three Molecules Are Enough to Start Silencing Genes - and Steer a Stem Cell's Fate

There is a standing puzzle in cell biology about how cells stay themselves. A liver cell and a neuron carry the same DNA, yet they behave utterly differently - and keep behaving differently through every cell division for the life of an organism. The answer involves gene silencing: specific regions of the genome are physically organized into repressive structures that keep the wrong genes quiet in each cell type. But the mechanics of how those structures assemble, particularly when the key proteins are present in vanishingly small numbers, has remained murky.

A study published in Molecular Cell from a team led by the University of North Carolina at Charlotte has produced a surprisingly clean answer to one version of that question. Using ultra-sensitive single-molecule imaging, the researchers counted individual proteins inside living cells and found that the structures controlling gene silencing in mouse embryonic stem cells form around a core of just three molecules of a protein called CBX2.

Three. Not hundreds. Not thousands. Three molecules of one of the least abundant Polycomb proteins in the stem cell nucleus can initiate the assembly of a large regulatory structure that shapes which genes are expressed across an entire developmental program.

Counting proteins one at a time

The technical challenge here is considerable. CBX2 is scarce. Classical biochemical methods - the blots and pull-downs that fill most cell biology papers - work best when proteins are present at high levels. When a molecule exists in only a handful of copies per cell, those methods become unreliable. The Tsukuba team's choice to use quantitative single-molecule imaging addressed this directly, making it possible to count molecules individually rather than infer their abundance from population averages.

What they found was that condensates - the liquid-like droplets of protein and chromatin that form repressive hubs in the nucleus - nucleate around three CBX2 molecules in mouse embryonic stem cells. As cells differentiate into neural progenitor cells, that number rises to roughly fifteen CBX2 molecules per condensate. The change in condensate composition tracks the change in cell identity.

What CBX2 actually does

CBX2 is part of the Polycomb repressive complex 1 (PRC1), a set of proteins that helps maintain gene silencing patterns across cell divisions. The new work shows that CBX2 does more than just contribute to an existing structure. Its ability to self-cluster is required to initiate the structure in the first place.

To test this, the researchers used CRISPR to engineer a variant of CBX2 called CBX2^PSM, which retains normal chromatin binding but cannot self-interact. The effects were striking. The variant failed to form condensates in live cells. In a test tube, it required more than 100 times higher concentrations to condense than normal CBX2. Despite binding to chromatin normally, a key histone modification called H3K27me3 - the molecular mark that signals gene repression - became mislocalized, accumulating in DNA-dense regions rather than at the proper Polycomb domains. Genome-wide profiling showed loss of H3K27me3 at normal target sites and gain at atypical ones.

Those effects closely mirrored what happens when CBX2 is knocked out entirely. The conclusion is that self-clustering, not just chromatin binding, is the essential function.

Cells that cannot choose their fate

The consequences extended into development itself. When the team induced differentiation in cells carrying the CBX2^PSM variant, embryoid bodies showed severely impaired outgrowth. The mutant cells failed to efficiently generate neural progenitor cells. The number of Nestin-positive cells - a marker of neural lineage - was significantly reduced compared to controls.

"Without CBX2's ability to self-cluster, the cells simply cannot execute their developmental programs," said Xiaojun Ren, the study's corresponding author and an associate professor at UNC Charlotte. The analogy he offered: just as a raindrop needs a tiny speck of dust to form in humid air, three CBX2 molecules act as the condensation nucleus for the entire repressive structure.

A new model for how these structures form

The findings challenge a common assumption about how Polycomb condensates assemble. With only three molecules per condensate in embryonic stem cells, CBX2 cannot form the kind of extensive interaction network that classical liquid-liquid phase separation requires. The team proposes instead a "nucleation and bridging induced phase separation" model: CBX2 binds to nucleation sites on chromatin, forming small CBX2-chromatin anchors; these recruit CBX7 and related PRC1 components that bridge chromatin fibers; PRC2 is then stabilized at these sites, promoting H3K27me3 deposition; and the condensate grows from there into a functional Polycomb domain.

That model reconciles previous in vitro and in vivo observations that had seemed contradictory and explains how proteins present at extremely low copy numbers can still initiate large-scale chromatin organization.

Polycomb dysfunction is linked to developmental disorders and multiple cancers. Understanding how condensates form and how their composition changes with cell fate provides a new angle on how gene-silencing programs are established - and what goes wrong when they fail. The Ren laboratory is supported in part by NIH grant R01GM135286 and the University of North Carolina at Charlotte.